DMAQR — Deep Medicine Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00- $57.84m
- $52.90m
- 41
- 54
- 59
- 50
Annual cashflow statement for Deep Medicine Acquisition, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.059 | -0.414 | -0.4 |
| Non-Cash Items | — | 0.004 | -1.82 |
| Unusual Items | |||
| Changes in Working Capital | 0.009 | -0.288 | 1.19 |
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Cash from Operating Activities | -0.05 | -0.698 | -1.04 |
| Other Investing Cash Flow Items | — | -128 | 120 |
| Change in Net Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | -128 | 120 |
| Financing Cash Flow Items | 0 | 129 | -121 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.55 | 129 | -120 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.5 | 0.377 | -0.282 |